NEWS & EVENTS
News: Variantyx Launches Its WGS-Based Prenatal Test for High-Risk Pregnancies, Enters Women’s Health Market
Variantyx, a leader in high complexity hereditary disease testing, announced today that it will launch its Genomic Unity® Prenatal Analysis test at the Society for Maternal Fetal Medicine’s 41st Annual Pregnancy Meeting being held virtually January 25-30 …
Events: SMFM’s 41st Annual Pregnancy Meeting
Join us at the Society for Maternal Fetal Medicine’s virtual conference!
Article: Ethics in Whole Genome Sequencing
The use of whole-genome sequencing (WGS) in diagnostic testing brings up the topic of secondary findings or incidental findings for many clinicians. Secondary findings are variants associated with a condition other than the one for which the patient is tested …